Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes

Diabetologia

Volumn 53, Issue 5, 2010, Pages 971-979

  Sasaki, M ^a   Ozawa, Y ^a   Kurihara, T ^a   Kubota, S ^a   Yuki, K ^a   Noda, K ^a,c   Kobayashi, S ^b   Ishida, S ^a,c   Tsubota, K ^a  

^a KEIO UNIVERSITY   (Japan)

^b Wakasa Seikatsu Co Ltd   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; BDNF; Diabetes; ERK; Lutein; Oxidative stress; Retina; ROS; Synaptophysin; Visual function

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; SYNAPTOPHYSIN; XANTHOPHYLL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIET SUPPLEMENTATION; IMMUNOBLOTTING; MOUSE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA GANGLION CELL; RETINA INNER PLEXIFORM LAYER; VISUAL IMPAIRMENT;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DIETARY SUPPLEMENTS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; LUTEIN; MICE; NERVE DEGENERATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RETINA; SYNAPTOPHYSIN;

EID: 77952089530     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1655-6     Document Type: Article

References (47)

1. AJ Barber 2003 A new view of diabetic retinopathy: a neurodegenerative disease of the eye Prog Neuropsychopharmacol Biol Psychiatry 27 283 290 10.1016/S0278-5846(03)00023-X 1:CAS:528:DC%2BD3sXit12ntrk%3D 12657367 (Pubitemid 36351495)
2. P Dandona K Thusu S Cook, et al. 1996 Oxidative damage to DNA in diabetes mellitus Lancet 347 444 445 10.1016/S0140-6736(96)90013-6 1:STN:280: DyaK287ptVWquw%3D%3D 8618487 (Pubitemid 26054071)
3. HB Lee MR Yu Y Yang Z Jiang H Ha 2003 Reactive oxygen species-regulated signaling pathways in diabetic nephropathy J Am Soc Nephrol 14 S241 S245 10.1097/01.ASN.0000077410.66390.0F 1:CAS:528:DC%2BD3sXmslCqsL0%3D 12874439 (Pubitemid 36903933)
4. L Zheng Y Du C Miller, et al. 2007 Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes Diabetologia 50 1987 1996 10.1007/s00125-007- 0734-9 1:CAS:528:DC%2BD2sXos1CjtLY%3D 17583794 (Pubitemid 47222853)
5. A Rivero C Mora M Muros J Garcia H Herrera JF Navarro-Gonzalez 2009 Pathogenic perspectives for the role of inflammation in diabetic nephropathy Clin Sci (Lond) 116 479 492 10.1042/CS20080394 1:CAS:528:DC%2BD1MXhslSit7Y%3D
6. M Sasaki Y Ozawa T Kurihara, et al. 2009 Neuroprotective effect of an antioxidant, lutein, during retinal inflammation Invest Ophthalmol Vis Sci 50 1433 1439 10.1167/iovs.08-2493 18997089
7. K Izumi-Nagai N Nagai K Ohgami, et al. 2007 Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization Arterioscler Thromb Vasc Biol 27 2555 2562 10.1161/ATVBAHA.107.151431 1:CAS:528:DC%2BD2sXhtlahtLvO 17932319 (Pubitemid 350158905)
8. T Kurihara Y Ozawa N Nagai, et al. 2008 Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina Diabetes 57 2191 2198 10.2337/db07-1281 1:CAS:528: DC%2BD1cXps1OisLs%3D 18487452
9. BV Bui JA Armitage M Tolcos ME Cooper AJ Vingrys 2003 ACE inhibition salvages the visual loss caused by diabetes Diabetologia 46 401 408 1:CAS:528:DC%2BD3sXksVWjtbY%3D 12687339 (Pubitemid 36547596)
10. CJ Dong P Agey WA Hare 2004 Origins of the electroretinogram oscillatory potentials in the rabbit retina Vis Neurosci 21 533 543 10.1017/ S0952523804214043 15579219 (Pubitemid 40007266)
11. J Kizawa S Machida T Kobayashi Y Gotoh D Kurosaka 2006 Changes of oscillatory potentials and photopic negative response in patients with early diabetic retinopathy Jpn J Ophthalmol 50 367 373 10.1007/s10384-006-0326-0 16897223 (Pubitemid 44167446)
12. HA Hancock TW Kraft 2004 Oscillatory potential analysis and ERGs of normal and diabetic rats Invest Ophthalmol Vis Sci 45 1002 1008 10.1167/iovs.03-1080 14985323 (Pubitemid 38868404)
13. Y Shirao K Kawasaki 1998 Electrical responses from diabetic retina Prog Retin Eye Res 17 59 76 10.1016/S1350-9462(97)00005-0 1:STN:280: DyaK1c7nsl2jsw%3D%3D 9537795 (Pubitemid 28040753)
14. T Kurihara Y Ozawa K Shinoda, et al. 2006 Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation Invest Ophthalmol Vis Sci 47 5545 5552 10.1167/iovs.06-0478 17122147 (Pubitemid 46723808)
15. AJ Barber E Lieth SA Khin DA Antonetti AG Buchanan TW Gardner 1998 Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin J Clin Invest 102 783 791 10.1172/JCI2425 1:CAS:528:DyaK1cXlsFaqsrg%3D 9710447 (Pubitemid 28399611)
16. PM Martin P Roon TK Van Ells V Ganapathy SB Smith 2004 Death of retinal neurons in streptozotocin-induced diabetic mice Invest Ophthalmol Vis Sci 45 3330 3336 10.1167/iovs.04-0247 15326158 (Pubitemid 39121873)
17. TS Kern AJ Barber 2008 Retinal ganglion cells in diabetes J Physiol 586 4401 4408 10.1113/jphysiol.2008.156695 1:CAS:528:DC%2BD1cXht1SnsL3J 18565995
18. TK Ali S Matragoon BA Pillai GI Liou AB El-Remessy 2008 Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes Diabetes 57 889 898 10.2337/db07-1669 1:CAS:528:DC%2BD1cXksVGktbY%3D 18285558
19. M Seki T Tanaka H Nawa, et al. 2004 Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells Diabetes 53 2412 2419 10.2337/diabetes.53.9.2412 1:CAS:528:DC%2BD2cXns1ShsLw%3D 15331553 (Pubitemid 39145597)
20. J Curran-Celentano BR Hammond Jr TA Ciulla DA Cooper LM Pratt RB Danis 2001 Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population Am J Clin Nutr 74 796 802 1:CAS:528:DC%2BD3MXovVSgtbw%3D 11722962 (Pubitemid 33101801)
21. JH Dwyer M Navab KM Dwyer, et al. 2001 Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles Atherosclerosis Study Circulation 103 2922 2927 1:CAS:528:DC%2BD3MXltlyitrY%3D 11413081 (Pubitemid 32578129)
22. WM Broekmans TT Berendschot IA Klopping-Ketelaars, et al. 2002 Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin Am J Clin Nutr 76 595 603 1:CAS:528:DC%2BD38XmslSntrc%3D 12198005
23. Y Ozawa K Nakao T Kurihara, et al. 2008 Roles of STAT3/SOCS3 pathway in regulating the visual function and ubiquitin-proteasome-dependent degradation of rhodopsin during retinal inflammation J Biol Chem 283 24561 24570 10.1074/jbc.M802238200 1:CAS:528:DC%2BD1cXhtVGktb3E 18614536
24. SP Sundelin SE Nilsson 2001 Lipofuscin-formation in retinal pigment epithelial cells is reduced by antioxidants Free Radic Biol Med 31 217 225 10.1016/S0891-5849(01)00573-1 1:CAS:528:DC%2BD3MXkvVeltbg%3D 11440833 (Pubitemid 32607588)
25. XH Jin K Ohgami K Shiratori, et al. 2006 Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats Invest Ophthalmol Vis Sci 47 2562 2568 10.1167/iovs.05-1429 16723471 (Pubitemid 351639842)
26. T Nishikawa D Edelstein XL Du, et al. 2000 Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 787 790 10.1038/35008121 1:CAS:528:DC%2BD3cXjtVals70%3D 10783895 (Pubitemid 30212409)
27. DM Snodderly JD Auran FC Delori 1984 The macular pigment. II. Spatial distribution in primate retinas Invest Ophthalmol Vis Sci 25 674 685 1:CAS:528:DyaL2cXks12qsr8%3D 6724837
28. DM Snodderly PK Brown FC Delori JD Auran 1984 The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas Invest Ophthalmol Vis Sci 25 660 673 1:CAS:528: DyaL2cXks12qsr4%3D 6724836
29. JL Berka AJ Stubbs DZ Wang, et al. 1995 Renin-containing Muller cells of the retina display endocrine features Invest Ophthalmol Vis Sci 36 1450 1458 1:STN:280:DyaK2M3ptlKjsQ%3D%3D 7775123
30. L Wachtmeister 1998 Oscillatory potentials in the retina: what do they reveal Prog Retin Eye Res 17 485 521 10.1016/S1350-9462(98)00006-8 1:STN:280:DyaK1cvltVyhsQ%3D%3D 9777648 (Pubitemid 28432979)
31. H Heynen L Wachtmeister D van Norren 1985 Origin of the oscillatory potentials in the primate retina Vision Res 25 1365 1373 10.1016/0042-6989(85) 90214-7 1:STN:280:DyaL287isVOhtQ%3D%3D 4090272 (Pubitemid 16235074)
32. D Yonemura K Kawasaki 1979 New approaches to ophthalmic electrodiagnosis by retinal oscillatory potential, drug-induced responses from retinal pigment epithelium and cone potential Doc Ophthalmol 48 163 222 10.1007/BF00207350 1:STN:280:DyaL3c7jtl2kug%3D%3D 119621 (Pubitemid 10146549)
33. I Spiwoks-Becker L Vollrath MW Seeliger G Jaissle LG Eshkind RE Leube 2001 Synaptic vesicle alterations in rod photoreceptors of synaptophysin- deficient mice Neuroscience 107 127 142 10.1016/S0306-4522(01)00345-1 1:CAS:528:DC%2BD3MXptVSgt7k%3D 11744253 (Pubitemid 34020691)
34. H Dudek SR Datta TF Franke, et al. 1997 Regulation of neuronal survival by the serine-threonine protein kinase Akt Science 275 661 665 10.1126/science.275.5300.661 1:CAS:528:DyaK2sXptV2msA%3D%3D 9005851 (Pubitemid 27061332)
35. K Ikegami T Koike 2000 Membrane depolarization-mediated survival of sympathetic neurons occurs through both phosphatidylinositol 3-kinase-and CaM kinase II-dependent pathways Brain Res 866 218 226 10.1016/S0006-8993(00)02284-8 1:CAS:528:DC%2BD3cXjsVGisLw%3D 10825497 (Pubitemid 30313024)
36. M Sano K Fukuda T Sato, et al. 2001 ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts Circ Res 89 661 669 10.1161/hh2001.098873 1:CAS:528:DC%2BD3MXnsF2kt70%3D 11597988 (Pubitemid 34627065)
37. K Kohara A Kitamura M Morishima T Tsumoto 2001 Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons Science 291 2419 2423 10.1126/science.1057415 1:CAS:528:DC%2BD3MXit1Kms7s%3D 11264540 (Pubitemid 32231806)
38. DK Binder HE Scharfman 2004 Brain-derived neurotrophic factor Growth Factors 22 123 131 10.1080/08977190410001723308 1:CAS:528:DC%2BD2cXpt1alu7c%3D 15518235 (Pubitemid 39377904)
39. AM Lohof NY Ip MM Poo 1993 Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF Nature 363 350 353 10.1038/363350a0 1:CAS:528:DyaK3sXksVWrsL8%3D 8497318 (Pubitemid 23161530)
40. JE Johnson YA Barde M Schwab H Thoenen 1986 Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells J Neurosci 6 3031 3038 1:CAS:528:DyaL28XmtF2lsbs%3D 2876066 (Pubitemid 16026084)
41. AJ Barber DA Antonetti TS Kern, et al. 2005 The Ins2Akita mouse as a model of early retinal complications in diabetes Invest Ophthalmol Vis Sci 46 2210 2218 10.1167/iovs.04-1340 15914643
42. MJ Gastinger RS Singh AJ Barber 2006 Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas Invest Ophthalmol Vis Sci 47 3143 3150 10.1167/iovs.05-1376 16799061 (Pubitemid 351639794)
43. SS Zhan K Beyreuther HP Schmitt 1993 Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia Dementia 4 66 74 1:STN:280: DyaK3szmsVGjtA%3D%3D 8358515 (Pubitemid 23125353)
44. HS Phillips JM Hains M Armanini GR Laramee SA Johnson JW Winslow 1991 BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease Neuron 7 695 702 10.1016/0896-6273(91)90273-3 1:CAS:528: DyaK38Xht1KisLo%3D 1742020
45. A Alves-Rodrigues A Shao 2004 The science behind lutein Toxicol Lett 150 57 83 10.1016/j.toxlet.2003.10.031 1:CAS:528:DC%2BD2cXivVWmsLw%3D 15068825 (Pubitemid 38447237)
46. Y Ozawa S Ishida K Tsubota 2008 Age-related macular degeneration (AMD); from pathogenesis and approved therapies to proposed treatments for prevention Anti-Aging Medicine 5 81 82 10.3793/jaam.5.87
47. L Brazionis K Rowley C Itsiopoulos K O'Dea 2009 Plasma carotenoids and diabetic retinopathy Br J Nutr 101 270 277 10.1017/S0007114508006545 1:CAS:528:DC%2BD1MXhtlCkur0%3D 18554424